Boissel JP - Search Results

1

Effect model law: an approach for the implementation of personalized medicine.

Boissel JP, Kahoul R, Marin D, Boissel FH. Boissel JP, et al. Among authors: boissel fh. J Pers Med. 2013 Aug 15;3(3):177-90. doi: 10.3390/jpm3030177. J Pers Med. 2013. PMID: 25562651 Free PMC article. Review.

2

Towards personalized medicine: exploring the consequences of the effect model-based approach.

Boissel JP, Kahoul R, Amsallem E, Gueyffier F, Haugh M, Boissel FH. Boissel JP, et al. Among authors: boissel fh. Per Med. 2011 Sep;8(5):581-586. doi: 10.2217/pme.11.54. Per Med. 2011. PMID: 29793254

3

Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population.

Kahoul R, Gueyffier F, Amsallem E, Haugh M, Marchant I, Boissel FH, Boissel JP. Kahoul R, et al. Among authors: boissel fh, boissel jp. J R Soc Interface. 2014 Nov 6;11(100):20140867. doi: 10.1098/rsif.2014.0867. J R Soc Interface. 2014. PMID: 25209407 Free PMC article.

4

From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work.

Boissel JP, Cogny F, Marko N, Boissel FH. Boissel JP, et al. Drugs Real World Outcomes. 2019 Sep;6(3):125-132. doi: 10.1007/s40801-019-0159-z. Drugs Real World Outcomes. 2019. PMID: 31359347 Free PMC article.

5

Level of evidence and therapeutic evaluation: need for more thoughts.

Bossard N, Boissel FH, Boissel JP. Bossard N, et al. Among authors: boissel fh, boissel jp. Fundam Clin Pharmacol. 2004 Jun;18(3):365-72. doi: 10.1111/j.1472-8206.2004.00240.x. Fundam Clin Pharmacol. 2004. PMID: 15147289 Review.

6

Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?

Courcelles E, Boissel JP, Massol J, Klingmann I, Kahoul R, Hommel M, Pham E, Kulesza A. Courcelles E, et al. Among authors: boissel jp. Front Med Technol. 2022 Feb 24;4:810315. doi: 10.3389/fmedt.2022.810315. eCollection 2022. Front Med Technol. 2022. PMID: 35281671 Free PMC article.

7

Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions.

Arsène S, Couty C, Faddeenkov I, Go N, Granjeon-Noriot S, Šmít D, Kahoul R, Illigens B, Boissel JP, Chevalier A, Lehr L, Pasquali C, Kulesza A. Arsène S, et al. Among authors: boissel jp. Nat Commun. 2022 Apr 13;13(1):1980. doi: 10.1038/s41467-022-29534-8. Nat Commun. 2022. PMID: 35418135 Free PMC article.

8

The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies.

Marchant I, Nony P, Cucherat M, Boissel JP, Thomas SR, Bejan-Angoulvant T, Laugerotte A, Kahoul R, Gueyffier F. Marchant I, et al. Among authors: boissel jp. PLoS One. 2011 Mar 3;6(3):e17508. doi: 10.1371/journal.pone.0017508. PLoS One. 2011. PMID: 21408615 Free PMC article.

9

Better defining target populations for drugs with a view to reimbursement.

Massol J, Boissel JP. Massol J, et al. Among authors: boissel jp. Therapie. 2014 May-Jun;69(3):235-7. doi: 10.2515/therapie/2014027. Epub 2014 Jun 16. Therapie. 2014. PMID: 24927505

10

Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample.

Boissel JP, Pérol D, Décousus H, Klingmann I, Hommel M. Boissel JP, et al. PLoS One. 2021 Oct 11;16(10):e0258093. doi: 10.1371/journal.pone.0258093. eCollection 2021. PLoS One. 2021. PMID: 34634062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

437 results

Search Page